RecruitingNot ApplicableNCT05460611

1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia

A Pilot Study Evaluating the Safety and Efficacy of a 1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia

Sponsor

Montefiore Medical Center

Enrollment

10 participants

Start Date

Dec 7, 2023

Study Type

INTERVENTIONAL

Conditions

Scarring Alopecia androgenetic alopecia

Summary

Single-center, open-label, baseline-controlled, pilot study evaluating the use of a Nonablative 1470 nm laser for the treatment of androgenetic alopecia and scarring alopecia.

Eligibility

Min Age: 18 YearsMax Age: 99 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Sciton HALO 1470nm Non-ablative laser for people with scarring alopecia and androgenetic alopecia. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 99 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.